Zivo Bioscience, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zivo Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Zivo Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.23M, a 351% decline year-over-year.
  • Zivo Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$13M, a 53.9% decline year-over-year.
  • Zivo Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$7.26M, a 16.8% increase from 2022.
  • Zivo Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$8.73M, a 1.01% decline from 2021.
  • Zivo Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$8.65M, a 1.05% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$13M -$8.23M -$6.41M -351% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$6.57M -$1.28M +$694K +35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$7.26M -$1.9M +$741K +28.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$8M -$1.57M +$428K +21.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$8.43M -$1.82M +$244K +11.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$8.68M -$1.97M +$56.3K +2.78% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$8.73M -$2.64M +$501K +16% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$9.23M -$2M -$327K -19.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$8.91M -$2.07M -$318K -18.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$8.59M -$2.03M +$57.1K +2.74% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$8.65M -$3.14M -$1.38M -78.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$7.26M -$1.67M +$1.69M +50.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.95M -$1.75M -$719K -69.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$8.23M -$2.08M +$323K +13.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$8.56M -$1.76M +$2.02M +53.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-22
Q3 2020 -$10.6M -$3.36M -$1.79M -114% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-04-21
Q2 2020 -$8.78M -$1.03M +$1.01M +49.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$9.79M -$2.41M -$1.44M -149% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$8.35M -$3.77M -$2.16M -133% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$6.2M -$1.57M -$79.1K -5.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$6.12M -$2.04M -$702K -52.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$5.42M -$968K +$715K +42.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$6.13M -$1.62M +$979K +37.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$7.11M -$1.49M +$566K +27.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 -$7.68M -$1.34M -$454K -51.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$7.22M -$1.68M -$892K -113% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$6.33M -$2.6M -$1.95M -304% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-12
Q3 2017 -$4.38M -$2.06M -$1.38M -204% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2.99M -$881K +$649K +42.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$3.64M -$791K -$151K -23.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-23
Q4 2016 -$3.49M -$643K +$21.1K +3.18% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-21
Q3 2016 -$3.51M -$677K +$111K +14.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-19
Q2 2016 -$3.62M -$1.53M -$488K -46.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$3.13M -$641K -$78.1K -13.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$3.06M -$664K +$1.81M +73.2% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-29
Q3 2015 -$4.87M -$788K +$308K +28.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$5.18M -$1.04M -$241K -30.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$4.94M -$562K +$216K +27.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$5.15M -$2.48M -$1.67M -208% Oct 1, 2014 Dec 31, 2014 10-K 2015-04-06
Q3 2014 -$3.48M -$1.1M -$208K -23.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.27M -$801K +$81.7K +9.26% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$3.35M -$779K -$243K -45.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$3.11M -$804K -$366K -83.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-06
Q3 2013 -$2.74M -$888K -$235K -36% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$2.51M -$882K -$401K -83.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.11M -$535K -$28.1K -5.54% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$2.08M -$438K +$524K +54.4% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-25
Q3 2012 -$2.6M -$653K -$368K -129% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$2.24M -$482K -$218K -82.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$2.02M -$507K -$79.3K -18.5% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-15
Q4 2011 -$1.94M -$962K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-25
Q3 2011 -$285K +$268K +48.5% Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-11-19
Q2 2011 -$264K +$1.55M +85.5% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-31
Q1 2011 -$428K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$553K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$1.82M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.